Navigation Links
Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™
Date:4/2/2012

WOOD DALE, Ill., April 2, 2012 /PRNewswire/ -- Smith Medical Partners, the specialty pharmaceutical subsidiary of H. D. Smith, today announced an exclusive logistics and cold chain services agreement with Cardium Therapeutics (NYSE Amex: CXM), a health sciences and regenerative medicine company, to support its recently launched wound care product, Excellagen™.  Excellagen is a professional-use, syringe-based wound care product used in the management of diabetic foot ulcers, pressure ulcers and other dermal wounds. 

"The secure and efficient distribution of specialty pharmaceutical products is a critical and growing need for the U.S. healthcare system – particularly because so many innovative medicines require specialized handling and dispensing," stated Dave DuRoss, president, Smith Medical Partners.  "Combining our logistics expertise with the manufacturing capabilities of leaders such as Cardium enables us to support the launch and distribution of specialty products that impact patient care, like Excellagen."

The U.S. Centers for Disease Control and Prevention (CDC) estimates that approximately 26 million people in the United States had diabetes in 2010(1). Diabetic foot ulcers, a major complication of diabetes, occur in 15 percent of diabetes patients and precede 84 percent of all lower leg amputations(2).  H. D. Smith and Smith Medical Partners are well positioned to provide distribution and specialized services along the entire specialty pharmaceutical supply chain – from the manufacturer to the patient. 

"As a growing segment of H. D. Smith's business, Smith Medical Partners seeks to be a leader in the specialty marketplace, offering a full-service model of support for manufacturers and customers – from bench to bedside," said Dale Smith, H. D. Smith Chief Executive Officer.  "The partnership with Cardium is the latest reflection of our ongoing commitment to patients across the country – ensuring that the healthcare providers and local pharmacies they depend on have the medicines they need, when they're needed.  We are pleased to work alongside Cardium in this critical mission to deliver medical advances for patients."

About Smith Medical Partners
As a wholly owned subsidiary of H. D. Smith, Smith Medical Partners focuses on specialty pharmaceutical distribution and services.  Smith Medical Partners delivers to healthcare providers lifesaving medicines and supplies, including a full line of brand pharmaceuticals, injectables, vaccines and a robust generics portfolio.  Licensed in all 50 states, Smith Medical Partners combines national reach with accessibility.  With a knowledgeable team focused on providing exceptional customer care and offering valuable insight on item selection, patient assistance programs and reimbursement solutions, Smith Medical Partners services hundreds of specialty pharmacies and thousands of physician offices and clinics of all sizes.  More than just product dispersal, Smith Medical Partners provides flexible offerings that facilitate cost-containment and efficiency throughout the supply chain, including helping manufacturers procure credentialed comparator products for clinical trials, third-party logistics and back-end telesales support for new and end of life cycle commercial products. 

Additional information about Smith Medical Partners can be found at smpspecialty.com.

(1) http://www.cdc.gov/media/releases/2011/p0126_diabetes.html
(2) Brem H, Tomic-Canic M.  Cellular and molecular basis of wound healing in diabetes.  J Clin Invest.  2007; 117(5): 1219-1222.  doi:10.1172/JCI32169.Tom Doyle

Mark MarmurSmith Medical Partners

Makovsky + Company, Inc.Vice President New Buisness Development

Assistant Vice President715.338.4518

212.508.9670tom.doyle@smpspecialty.com  

mmarmur@makovsky.com  


'/>"/>
SOURCE Smith Medical Partners
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
5. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
6. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
7. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
8. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
9. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
10. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
11. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 24, 2016 The innovator ... , s first dual therapy stent, introduces ... OrbusNeich, a global company specializing in the ... to include products to treat peripheral artery disease. The ... entry devices for lower limb and arteriovenous (AV) fistula ...
(Date:5/24/2016)... , May 24, 2016 Een ... verbindt, zodat zij collectief patiënten kunnen behandelen, hun kennis ... het idee achter de nieuwe en revolutionaire MDLinking App, ... de Nederlandse vaatchirurg dr. Hans Flu en oncologisch chirurg ... die inmiddels beschikbaar is, wordt op dinsdag 24 mei ...
(Date:5/23/2016)... , May 23, 2016 ... Market Size, Share, Development, Growth and Demand Forecast ... Single and Other), by Application (Drug Discovery and ... End Users (Pharmaceuticals, Life Science and Biotechnology, Academic ... P&S Market Research, the global mass spectrometry ...
Breaking Medicine Technology:
(Date:5/25/2016)... , ... May 25, 2016 , ... According to an ... type of hernia mesh that would effectively fight against common bacteria and protect against ... the healing process from hernia repair surgery even safer and could further ...
(Date:5/25/2016)... ... 25, 2016 , ... The Horizon Foundation for New Jersey ... to improve oral health-related awareness, education, prevention and treatment for young people. The ... promote best practices in 10 New Jersey counties where dental health needs among ...
(Date:5/25/2016)... ... , ... The Bank of America Charitable Foundation has awarded a grant to ... pathway to employment and successful careers in healthcare. On Wednesday, May 4th, Rick Bridwell, ... CEO of Medisend, parent organization and home of the General Myers Veterans Program. ...
(Date:5/25/2016)... ... 25, 2016 , ... Today American University of Antigua (AUA) ... announced the AUA-FIU Global MD Program. Students in the Global MD Program ... a Certificate of Completion from the FIU Herbert Wertheim College of Medicine Clinical ...
(Date:5/25/2016)... ... May 25, 2016 , ... Dr. Travis Schwarz is an experienced dentist who ... O’Fallon, MO 63366. He serves patients of all ages with a full menu of ... success is reflected in the superior patient reviews that he has consistently earned during ...
Breaking Medicine News(10 mins):